sanofi

Documents about sanofi

• Drug Delivery Device — Sanofi (US20220305206A1)#607580Google Patents
• Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry#802990ClinicalTrials.gov
• Dengvaxia US Pregnancy Registry#807074ClinicalTrials.gov
• Medicament Delivery Device — Sanofi-Aventis Deutschland Gmbh (US20250032718A1)#607359Google Patents
• Medicament delivery device — Sanofi-Aventis Deutschland Gmbh (US12409267B2)#607366Google Patents
• Medicament delivery device — Sanofi-Aventis Deutschland Gmbh (US12251542B2)#607369Google Patents
• Safety of Imovax Polio in Chinese Infants and Children#127671ClinicalTrials.gov
• Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America#885496ClinicalTrials.gov
• Postmarketing Surveillance Study for IMOJEV® in Republic of Korea#279570ClinicalTrials.gov
• Coded collapsible drug reservoir — Sanofi-Aventis Deutschland Gmbh (US11147739B2)#607374Google Patents
• Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine#1150907ClinicalTrials.gov
• Post Marketing Surveillance for ADACEL™ in South Korea#1185470ClinicalTrials.gov
• Phase 3 Single Arm, Open Study on vYF in Adults#1339774ClinicalTrials.gov
• Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults#201628ClinicalTrials.gov
• A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination#873389ClinicalTrials.gov
• Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children#866875ClinicalTrials.gov
• Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine#143657ClinicalTrials.gov
• Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy Adults#387194ClinicalTrials.gov
• A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine#683126ClinicalTrials.gov
• Irbesartan in Hypertension#846695ClinicalTrials.gov
• Dermacyd Infantile - Acceptability.#1214452ClinicalTrials.gov
• A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers#18690ClinicalTrials.gov
• Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly#125938ClinicalTrials.gov
• Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US#201607ClinicalTrials.gov
• Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines#429636ClinicalTrials.gov
• Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years#863060ClinicalTrials.gov
• BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)#917025ClinicalTrials.gov
• Study of Safety and Immunogenicity of Fluzone® in Healthy Children#1152407ClinicalTrials.gov
• Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine#471498ClinicalTrials.gov
• Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE#833165ClinicalTrials.gov
• Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults#895615ClinicalTrials.gov
• Post-licensure Safety Study of IMOJEV® in Thailand#969157ClinicalTrials.gov
• Sotagliflozin Bioequivalence Study#249511ClinicalTrials.gov
• Colorectal Cancer RECHALLENGE#879283ClinicalTrials.gov
• Amisulpride in Schizophrenic Patients#891648ClinicalTrials.gov
• High Density Lipoprotein Turnover#894665ClinicalTrials.gov
• APROVE : Irbesartan in Hypertension#898816ClinicalTrials.gov
• Drotaverine in Dysmenorrhoea Treatment#917275ClinicalTrials.gov
• Levofloxacin, Chronic Bacterial Prostatitis#1320897ClinicalTrials.gov
• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne#148579ClinicalTrials.gov
• Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine#154738ClinicalTrials.gov
• Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults#181609ClinicalTrials.gov
• Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly#803845ClinicalTrials.gov
• Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen#861361ClinicalTrials.gov
• Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents#901386ClinicalTrials.gov
• Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers#903956ClinicalTrials.gov
• Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia#981510ClinicalTrials.gov
• Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)#982105ClinicalTrials.gov
• Study of Quadrivalent Influenza Vaccine Among Children#1044646ClinicalTrials.gov
• Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam#1139711ClinicalTrials.gov